Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Pancreatic Neoplasms 1 Heartburn 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Cancer Screening 1 Barrett Esophagus 1

Interventions

Sunitinib 17 Sorafenib 16 pazopanib 7 cabozantinib 7 Axitinib 7 Blood Specimen Collection 6 Bevacizumab 6 avelumab 5 Immunohistochemistry 5 temsirolimus 4 pembrolizumab 3 Watchful Waiting 3 Specimen Handling 3 Immunotherapy 3 Gene Expression Profiling 3 Everolimus 3 Urine Specimen Collection 2 Nephrectomy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Flow Cytometry 2 Data Collection 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 lenvatinib 1 fluoroazomycin arabinoside 1 enfortumab vedotin 1 darolutamide 1 atezolizumab 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Renal Cell × Decision Support Techniques × Clear all

NCT05548621 2025-05-15

SDM-RCC

St. Antonius Hospital

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡